Mike Kelliher

Vice President, Business Development

Back to Speakers

With nearly 20 years commercial and financial experience, Mike Kelliher has spent the last nine years working in the healthcare industry. Within that time, Mike has led and supported acquisitions, divestments, corporate defence, collaboration and alliance management, commercial and royalty finance and strategic business reviews. Mike joined Horizon Pharma in November 2014 and now leads Horizon’s orphan business development efforts. He has led a number of Horizon’s rare disease acquisitions, as well as supported various elements of Horizon’s orphan business growth strategy, including Ex-U.S. commercial and operational reviews.
Prior to Horizon, Mike spent five years with Elan Pharmaceuticals in San Francisco and Dublin. There he supported the $3.25bn divestment of Elan’s interest in Tysabri to Biogen Idec in 2013, amongst other business development activities. Prior to that Mike spent four years with PwC, where he qualified as a chartered accountant, gaining a wealth of financial and transactional experience. Mike began his career in commercial banking and wealth management, spending four years with Bank of Ireland in Dublin.